Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C41H48N2O8 |
| Molecular Weight | 696.8284 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C[C@@H]3N(C)CCC4=C3C2=C(OC)C(OC)=C4)C=C1OC5=CC(OC)=C(OC)C=C5C[C@@H]6N(C)CCC7=CC(OC)=C(OC)C=C67
InChI
InChIKey=ZCTJIMXXSXQXRI-KYJUHHDHSA-N
InChI=1S/C41H48N2O8/c1-42-12-10-23-16-32(44-3)34(46-5)20-27(23)29(42)15-26-19-33(45-4)36(48-7)22-31(26)51-37-18-25-14-30-39-24(11-13-43(30)2)17-38(49-8)41(50-9)40(39)28(25)21-35(37)47-6/h16-22,29-30H,10-15H2,1-9H3/t29-,30-/m0/s1
| Molecular Formula | C41H48N2O8 |
| Molecular Weight | 696.8284 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of isoquinoline alkaloids of different structural types on antiplatelet aggregation in vitro. | 2006-10 |
|
| Cytotoxic and antitumor potentialities of aporphinoid alkaloids. | 2005-03 |
|
| Membrane effects of the antitumor drugs doxorubicin and thaliblastine: comparison to multidrug resistance modulators verapamil and trans-flupentixol. | 2004-02 |
|
| The in vitro metabolism of thalicarpine, an aporphine-benzyltetrahydroisoquinoline alkaloid, in the rat. API-MS/MS identification of thalicarpine and metabolites. | 2002-08-22 |
|
| Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. | 1991-01-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:48:11 GMT 2025
by
admin
on
Mon Mar 31 17:48:11 GMT 2025
|
| Record UNII |
8X1D791RF6
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C932
Created by
admin on Mon Mar 31 17:48:11 GMT 2025 , Edited by admin on Mon Mar 31 17:48:11 GMT 2025
|
||
|
NCI_THESAURUS |
C67422
Created by
admin on Mon Mar 31 17:48:11 GMT 2025 , Edited by admin on Mon Mar 31 17:48:11 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m10672
Created by
admin on Mon Mar 31 17:48:11 GMT 2025 , Edited by admin on Mon Mar 31 17:48:11 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID90202011
Created by
admin on Mon Mar 31 17:48:11 GMT 2025 , Edited by admin on Mon Mar 31 17:48:11 GMT 2025
|
PRIMARY | |||
|
5373-42-2
Created by
admin on Mon Mar 31 17:48:11 GMT 2025 , Edited by admin on Mon Mar 31 17:48:11 GMT 2025
|
PRIMARY | |||
|
9509
Created by
admin on Mon Mar 31 17:48:11 GMT 2025 , Edited by admin on Mon Mar 31 17:48:11 GMT 2025
|
PRIMARY | |||
|
68075
Created by
admin on Mon Mar 31 17:48:11 GMT 2025 , Edited by admin on Mon Mar 31 17:48:11 GMT 2025
|
PRIMARY | |||
|
C073328
Created by
admin on Mon Mar 31 17:48:11 GMT 2025 , Edited by admin on Mon Mar 31 17:48:11 GMT 2025
|
PRIMARY | |||
|
8X1D791RF6
Created by
admin on Mon Mar 31 17:48:11 GMT 2025 , Edited by admin on Mon Mar 31 17:48:11 GMT 2025
|
PRIMARY | |||
|
21470
Created by
admin on Mon Mar 31 17:48:11 GMT 2025 , Edited by admin on Mon Mar 31 17:48:11 GMT 2025
|
PRIMARY | |||
|
C869
Created by
admin on Mon Mar 31 17:48:11 GMT 2025 , Edited by admin on Mon Mar 31 17:48:11 GMT 2025
|
PRIMARY |